We used human transcriptomic and clinical data from the Nephrotic Syndrome Study Network (NEPTUNE) to demonstrate that SH3BP2, its partner molecules (especially PLCγ2 and VAV2), and innate immune signaling pathways are upregulated in the glomerular transcriptome in nephrotic syndrome. The gene discussed is PLCG2; the disease is nephrotic syndrome.